Lv11
94 积分 2025-01-21 加入
Metabolic reprogramming-driven resistance to multi-kinase inhibitors in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities
1个月前
已完结
Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration
5个月前
已完结
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
8个月前
已完结
Disrupting cellular memory to overcome drug resistance
1年前
已关闭
M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/β-catenin and Hippo signaling pathways
1年前
已完结
皖公网安备34019202002308
